The Hirshberg Foundation is pleased to have three UCLA doctors, Dr. Hines, Dr. King and Dr. Girgis update us on surgery options and new techniques, including robotic surgery, that are now available to pancreatic cancer patients.
Jonathan King, MD, is an Assistant Professor in the Division of General Surgery at UCLA. He attended the University of Maryland for his M.D. degree before coming to UCLA for his general surgery residency. After residency, Dr. King spent two years in Pittsburgh, PA (UPMC) for a surgical oncology fellowship before returning to Los Angeles to join the surgery faculty.
He is board certified in Complex Surgical Oncology and has particular interest in pancreatic cancer and disseminated peritoneal malignancies. He has expertise in robotic-assisted minimally invasive pancreas surgery and performed UCLA’s first minimally-invasive pancreaticoduodenectomy (Whipple procedure) and has started UCLA’s program for hyperthermic intraperitoneal chemoperfusion (HIPEC). In addition to his clinical interests, Dr. King is a translational and clinical investigator with active research interests in the biology of exosomes and pancreatic cancer metastasis. He has authored numerous peer-reviewed manuscripts and abstracts as well as book chapters in some of the authoritative surgical textbooks. Dr. King is an enthusiastic surgical educator and is developing the UCLA residency training curriculum for robotic-assisted surgery and he is a member of numerous professional societies.
Dr. King will speak on Advances in Pancreatic Surgery, specifically how robotic-assisted minimally invasive surgery is benefiting patients.
